Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP869837.RAmBZpuM6CfwYUwEW32X0fZ3bn4FWaK5slOvIZyioQvMY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP869837.RAmBZpuM6CfwYUwEW32X0fZ3bn4FWaK5slOvIZyioQvMY130_assertion type Assertion NP869837.RAmBZpuM6CfwYUwEW32X0fZ3bn4FWaK5slOvIZyioQvMY130_head.
- NP869837.RAmBZpuM6CfwYUwEW32X0fZ3bn4FWaK5slOvIZyioQvMY130_assertion description "[MK2206 also completely overcame the feedback activation of Akt from temsirolimus-induced mammalian target of rapamycin suppression, and the two inhibitors synergistically inhibited thyroid cancer cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869837.RAmBZpuM6CfwYUwEW32X0fZ3bn4FWaK5slOvIZyioQvMY130_provenance.
- NP869837.RAmBZpuM6CfwYUwEW32X0fZ3bn4FWaK5slOvIZyioQvMY130_assertion evidence source_evidence_literature NP869837.RAmBZpuM6CfwYUwEW32X0fZ3bn4FWaK5slOvIZyioQvMY130_provenance.
- NP869837.RAmBZpuM6CfwYUwEW32X0fZ3bn4FWaK5slOvIZyioQvMY130_assertion SIO_000772 21289267 NP869837.RAmBZpuM6CfwYUwEW32X0fZ3bn4FWaK5slOvIZyioQvMY130_provenance.
- NP869837.RAmBZpuM6CfwYUwEW32X0fZ3bn4FWaK5slOvIZyioQvMY130_assertion wasDerivedFrom befree-2016 NP869837.RAmBZpuM6CfwYUwEW32X0fZ3bn4FWaK5slOvIZyioQvMY130_provenance.
- NP869837.RAmBZpuM6CfwYUwEW32X0fZ3bn4FWaK5slOvIZyioQvMY130_assertion wasGeneratedBy ECO_0000203 NP869837.RAmBZpuM6CfwYUwEW32X0fZ3bn4FWaK5slOvIZyioQvMY130_provenance.